The tumor-infiltrating CD39+CD103+CD8+T cells were tumor-reactive immune cells, and the increase of tumor-infiltrating CD103+CD39+CD8+T cells was associated with better overall survival in head and neck cancer (41). The gene discussed is ENTPD1; the disease is head and neck cancer.